Daily Stock Opinions and Ratings

Opinions

Robert Floyd ID Biomedical IDB-T BUY ON WEAKNESS Sep 22, 2003

Likes the story. Has had a pretty good run, but has more room to go. Very strong news out of the company. Some trial results still to come out in the next little while.

Robert Floyd

Unknown

Unlock Rating

$25.470

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

PAST TOP PICK

(Was a top pick on Dec 21 up 50%) Can still go higher.

BUY

Still has substantial upside. Into some interesting products.

WEAK BUY

Very volatile. Well managed and has a lot of cash.

BUY

Good product. In final phases of testing.

BUY ON WEAKNESS

Developing a flu vaccine. Well cashed up. Would buy it, but at a lower level.

BUY

The pharmaceutical sector has been torn apart. This company that has done a very good job in managing and developing some products.

DON'T BUY

Biotech stocks are very risky. This one has done very well on the flu vaccine problem in the US. A low margin business. Very expensive.

BUY

Have a large vaccine contract in the US. Should have a large increase in earnings and the stock should have a lot of upside.

HOLD

GlaxcoSmithKline (GSK-N) is taking the company over. Speculation is that someone else will come in with a better offer. Can't see much risk in holding on to your shares.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Robert Floyd ID Biomedical IDB-T BUY ON WEAKNESS Sep 22, 2003

You might be interested:

ID Biomedical(IDB-T)

ID Biomedical(IDB-T)

ID Biomedical(IDB-T)

ID Biomedical(IDB-T)

ID Biomedical(IDB-T)

ID Biomedical(IDB-T)

ID Biomedical(IDB-T)

ID Biomedical(IDB-T)

ID Biomedical(IDB-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Bruce Murray

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Chris Blumas

Stockchase Insights